Milosević R, Janković G, Antonijević N, Jovanović V, Babić D, Colović M
Institute of Haematology, Clinical Centre of Serbia, Belgrade.
Srp Arh Celok Lek. 2000 May-Jun;128(5-6):200-4.
Histopathologic findings in bone marrow biopsies in patients are with aplastic anaemia crucial for the diagnosis of the disease. Changes observed by the examination of bone marrow such as cellularity, histopathologic type, presence of irregular cells maturation in all three blood lineages, condition of medullar stroma can be of great prognostic significance [1, 2, 4, 5]. The aim of the study was to make histopathological analyses in patients with aplastic anaemia and to establish parameters significant for the prognosis of the disease.
Thirty-three patients with aplastic anaemia treated in the Institute of Haematology, Clinical Centre of Serbia, from 1988 to 1995 were included in the study. Bone marrow specimens were analysed for: cellularity, number of megakaryocytes, condition of medullar stroma, presence/absence of blood and oedema, lymphoid elements, presence of plasma and reticular cells, and determination of histopathologic type on the basis of bone marrow changes. For data description we used the arithmetic mean and standard deviation for parametric results. Results of analyses were explained by Kaplan-Mayer's method and two factors analysis of variance.
In all analysed marrow biopsy specimens a 100% hypocellularity was observed: 1. Weak hypocellularity in two specimens (6%); 2. Mild hypocellularity in six cases (19%); 3. Severe hypocellularity in 24 (75%), In one case (3%) the finding was not known. In 25 specimens (75%) megakaryocytes were not found, in 5 (16%) they were rare; in two cases (6%) they were numerous. Medullar stroma changes were not found in 30 (94%) byopsies, but in two (6%) they were found. Blood and oedema liquid were found in 26 (81%) cases and not in 6 (19%). Lympho-plasmocytic bone marrow infiltration was found in 23 specimens (72%) and not in nine (28%). First histopathologic types two (one-a and one-b) were present in 25 (78%) cases, histopathologic type two in 5 (16%) and type three in 2 (6%) specimens. The two factors analysis of variance regarding proportions between dead and alive patients revealed a significant difference in proportions according to histopathologic types (FD = 7.52; DF = 2; p = 0.002). Significant statistical differences were found between alive and dead patients in all three histopathologic types, tip one (one-a and one-b) (FD = 8; DF = 1; p = 0.06); type two (FD = 4.286; DF = 1; p = 0.041) and type three (FD = 4.762; DF = 1; p = 0.031). Histopathologic type two had the best prognosis regarding survival probability; p = 0.800; in histopathologic type two survival prognosis was worse p = 0.300, and type three it was the worst, p = 0.000. With regard to survival time, there was no statistical difference in patients with weak and mild bone marrow hypocellularity (p = 0.487). We also compared patients with severe bone marrow hypocellularity with patients with weak and mild hypocellularity. The difference in survival was statistically significant (p = 0.026), Consequently, survival was shorter in patients with severe bone marrow hypocellularity.
Bone marrow biopsy and histopathologic examination are necessary for definitive diagnosis of aplastic anaemia [1-3]. Cellularity estimation in bone marrow based on biopsy and histopathologic examination is more reliable than that made by bone marrow aspiration [7]. Aplastic anaemia is a disease that can be associated with abnormal clones development. Most frequently paroxysmal nocturnal haemoglobinuria, acute leukaemias and myelodysplastic syndrome occur. Therefore, repeated bone marrow biopsies are necessary to follow-up the course of the disease [10, 11]. The presence of megakaryocytes in bone marrow specimens has favourable prognostic significance. Their appearance is a reliable sign of disease improvement [6, 7]. However, lymphocytosis, plasmocytosis and damaged marrow stroma are markers of bad prognosis [7]. (ABSTRACT TRUNCATED)
再生障碍性贫血患者骨髓活检的组织病理学结果对该疾病的诊断至关重要。通过骨髓检查观察到的变化,如细胞密度、组织病理学类型、所有三个血细胞系中不规则细胞成熟的存在情况、骨髓基质状况等,可能具有重要的预后意义[1,2,4,5]。本研究的目的是对再生障碍性贫血患者进行组织病理学分析,并确定对该疾病预后有意义的参数。
本研究纳入了1988年至1995年在塞尔维亚临床中心血液学研究所接受治疗的33例再生障碍性贫血患者。对骨髓标本进行了以下分析:细胞密度、巨核细胞数量、骨髓基质状况、有无血液和水肿、淋巴样成分、浆细胞和网状细胞的存在情况,并根据骨髓变化确定组织病理学类型。对于数据描述,我们使用参数结果的算术平均值和标准差。分析结果采用Kaplan - Mayer法和双因素方差分析进行解释。
在所有分析的骨髓活检标本中,均观察到100%的细胞减少:1. 两个标本(6%)为轻度细胞减少;2. 六个病例(19%)为中度细胞减少;3. 24个(75%)为重度细胞减少,一例(3%)结果未知。25个标本(75%)未发现巨核细胞,5个(16%)巨核细胞罕见;两例(6%)巨核细胞数量较多。30例(94%)活检未发现骨髓基质变化,但两例(6%)发现有变化。26例(81%)病例发现有血液和水肿液,6例(19%)未发现。23个标本(72%)发现淋巴细胞 - 浆细胞骨髓浸润,9个(28%)未发现。25例(78%)病例存在两种组织病理学类型(各一例a型和b型),5例(16%)为组织病理学类型二,2个标本(6%)为组织病理学类型三。关于死亡和存活患者比例的双因素方差分析显示,根据组织病理学类型,比例存在显著差异(FD = 7.52;DF = 2;p = 0.002)。在所有三种组织病理学类型中,存活和死亡患者之间均发现有显著统计学差异,类型一(a型和b型)(FD = 8;DF = 1;p = 0.06);类型二(FD = 4.286;DF = 1;p = 0.041)和类型三(FD = 4.762;DF = 1;p = 0.031)。组织病理学类型二的生存概率预后最佳;p = 0.80;组织病理学类型一的生存预后较差,p = 0.30,类型三最差,p = 0.000。关于生存时间,轻度和中度骨髓细胞减少患者之间无统计学差异(p = 0.487)。我们还比较了重度骨髓细胞减少患者与轻度和中度细胞减少患者。生存差异具有统计学意义(p = 0.026),因此,重度骨髓细胞减少患者的生存时间较短。
骨髓活检和组织病理学检查对于再生障碍性贫血的明确诊断是必要的[1 - 3]。基于活检和组织病理学检查对骨髓细胞密度的估计比骨髓穿刺更可靠[7]。再生障碍性贫血是一种可能与异常克隆发展相关的疾病。最常见的是阵发性夜间血红蛋白尿、急性白血病和骨髓增生异常综合征。因此,需要重复进行骨髓活检以跟踪疾病进程[10,11]。骨髓标本中巨核细胞的存在具有良好的预后意义。它们的出现是疾病改善的可靠标志[6,7]。然而,淋巴细胞增多、浆细胞增多和骨髓基质受损是预后不良的标志物[7]。(摘要截断)